Targovax ASA (GB:0RIS) has released an update.
Circio Holding ASA has seen its Chief Technology Officer, Thomas Birkballe Hansen, exercise 46,800 warrants at a price of NOK 0.60 per share, marking a key development in the company’s stock activity. This exercise is part of a larger issuance of 13,864,852 warrants related to a rights issue from July 2024. Circio continues to advance its cutting-edge RNA technology and cancer treatment projects, which could offer significant future value.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.